SARS2020

SARS2020 identifies and predicts enzymatic functions of novel coronaviruses from genomic sequences to support rapid pathogen identification and functional characterization.

Key Features:

• Comprehensive Integration: Consolidates research findings, genomic sequences, and anti-viral drug trial outcomes related to coronaviruses.
• Consensus Sequence-Function Model: Implements a consensus sequence-catalytic function model to identify catalytic enzymes encoded by viral genomes, including the observation that the novel coronavirus encodes the same proteinase as the severe acute respiratory syndrome (SARS) virus.
• Data-Driven Strategy: Applies sequence-based predictive methods to infer biological functions from pathogen sequences for rapid agent identification.

Scientific Applications:

• Virus Identification: Identifies novel coronaviruses by detecting encoded enzymatic proteins and inferred catalytic functions.
• Drug Discovery and Development: Integrates anti-viral drug trial results with predicted viral functions to support exploration of potential therapeutic agents.
• Epidemiological Research: Provides functional insights into viral proteins to assist tracking viral evolution and propagation.

Methodology:

Uses a consensus sequence-catalytic function model to map pathogen genomic sequences to biological functions by analyzing genomic data to identify key enzymatic proteins and correlating those sequences with known viral characteristics.